Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 July 07, 2021 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 6

July 21, 2021 00:39:34
Episode Cover

Episode 6: Dr. Mehool Patel and Dr. Dilhan Weeraratne, IBM Watson Health

On today's podcast, host Wayne Bowden joins Biorasi's Omar Ibrahim and IBM Watson Health HOPE team members Dr. Mehool Patel and Dr. Dilhan Weeraratne...

Listen

Episode 11

September 28, 2021 00:34:38
Episode Cover

Episode 11: Rebecca Stewart and Nicola Miller from Rare Revolution Magazine

How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca...

Listen

Episode 4

June 23, 2021 00:38:12
Episode Cover

Episode 4: Marianne Clancy, Executive Director at Cure HHT

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about...

Listen